Cytokinetics to Present at September Investor Conferences

On September 3, 2019 Cytokinetics, Incorporated (Nasdaq: CYTK) reported that Robert I. Blum, President and Chief Executive Officer, is reported to present a corporate update at the following investor conferences (Press release, Cytokinetics, SEP 3, 2019, View Source [SID1234539268]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019 at 8:10 AM ET at the Grand Hyatt Hotel in New York City
21st Annual H. C. Wainwright Global Investment Conference on Tuesday, September 10, 2019 at 1:20 PM ET at the Lotte New York Palace Hotel in New York City
Interested parties may access the live webcast of these presentations by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com. The webcast replay of each presentation will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of each event.